Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial.
Journal Information
Full Title: J Nucl Med
Abbreviation: J Nucl Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nuclear Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the image-processing pipeline including the ai-based spleen segmentation feature extraction and survival analysis is publicly available at https://github com/kibromberihu/tumorlocationprofiler ."
"DISCLOSURE The REMARC clinical studies and analyses were sponsored by the Lymphoma Academic Research Organization (LYSARC) of France. Kibrom Girum and Irène Buvat received a research grant given to the Institut Curie by ANR (ANR-19-SYME-0005-03). Louis Rebaud was employed by Siemens Medical Solutions. No other potential conflict of interest relevant to this article was reported."
"The REMARC clinical studies and analyses were sponsored by the Lymphoma Academic Research Organization (LYSARC) of France. Kibrom Girum and Irène Buvat received a research grant given to the Institut Curie by ANR (ANR-19-SYME-0005-03). Louis Rebaud was employed by Siemens Medical Solutions. No other potential conflict of interest relevant to this article was reported."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025